A Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Determine the maximum tolerated dose (MTD) of SRS given in 3 fractions for brain metastases 4.2 - 14.1 cm3 and 14.2 - 33.5 cm3.
60 days (per patient)
United States: Institutional Review Board
|Stanford University School of Medicine||Stanford, California 94305-5317|